Logo image
Back
Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine
Journal article   Open access   Peer reviewed

Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine

Brian Latimer, Roberta Toporovski, Jian Yan, Panyupa Pankhong, Matthew P. Morrow, Amir S. Khan, Niranjan Y. Sardesai, Seth L. Welles, Jeffrey M. Jacobson, David B. Weiner, …
Human vaccines & immunotherapeutics, v 10(8), pp 2357-2365
01 Jan 2014
DOI: https://doi.org/10.4161/hv.29590
PMID: 25424943
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.4161/hv.29590View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze),  Open

Abstract

Biotechnology & Applied Microbiology Immunology Life Sciences & Biomedicine Science & Technology
Chronic HC V is a surreptitious disease currently affecting approximately 3% of the world's population that can lead to liver failure and cancer decades following initial infection. However, there are currently no vaccines available for the prevention of chronic HC V. From patients who acutely resolve HC V infection, it is apparent that a strong and broad cytotoxic T lymphocyte (CTL) response is important in HC V clearance. DNA vaccines are naked plasmid DNA molecules that encode pathogen antigens to induce a pathogen-specific immune response. They are inexpensive to produce and have an excellent safety profile in animals and humans. Additionally, DNA vaccines are able to induce strong CTL responses, making them well-suited for an HC V vaccine. We aimed to maximize vaccine recipients' opportunity to induce a broad T cell response with a novel antigenic sequence, multi-antigen vaccine strategy. We have generated DNA plasmids encoding consensus sequences of HC V genotypes 1a and 1b non-structural proteins NS3/4a, NS4b, NS5a, and NS5b. Rhesus macaques were used to study the immunogenicity of these constructs. Four animals were immunized 3 times, 6 weeks apart, at a dose of 1.0mg per antigen construct, as an intramuscular injection followed by in vivo electroporation, which greatly increases DNA uptake by local cells. Immune responses were measured 2 weeks post-immunization regimen (PIR) in immunized rhesus macaques and showed a broad response to multiple HC V nonstructural antigens, with up to 4680 spot-forming units per million peripheral blood mononuclear cells (PBMCs) as measured by Interferon-gamma ELISpot. In addition, multiparametric flow cytometry detected HC V-specific CD4+ and CD8+ T cell responses by intracellular cytokine staining and detected HC V-specific CD107a+/GrzB+ CD8+ T cells indicating an antigen specific cytolytic response 2 weeks PIR compared with baseline measurements. At the final study time point, 6 weeks PIR, HC V-specific CD45RA-memory-like T cells remained detectable in peripheral blood. Data presented in this manuscript support the notion that vaccine immunogenicity studies using a macaque model can be used to depict key anti-HC V nonstructural antigenic cellular immune responses and support the development of DNA-based prophylactic HC V vaccines.

Metrics

18 Record Views
19 citations in Web of Science
26 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Immunology
Logo image